; and (2) the term opioid means any chemical that binds to an opioid receptor and resembles opiates in its pharmacological effects. . (b) Report on medication assisted treatment for opioid and heroin abuse pilot program The Director of the Bureau of Prisons shall submit within 90 days of enactment of this Act to the Committees on the Judiciary and Appropriations of the Senate and the House of Representatives a report and evaluation of the current pilot program within the Bureau of Prisons to treat heroin and opioid abuse through medication assisted treatment. The report shall include a description of plans to expand access to medication assisted treatment for heroin and opioid abuse for Federal prisoners in appropriate cases. (c) Report on the availability of medication assisted treatment for opioid and heroin abuse Within 90 days after the date of the enactment of this Act, the Director of the Administrative Office of the United States Courts shall submit a report to the Committees on the Judiciary and Appropriations of the Senate and the House of Representatives assessing the availability of and capacity for the provision of medication assisted treatment for opioid and heroin abuse among treatment-service providers serving Federal offenders under supervised release and including a description of plans to expand access to medication assisted treatment that is not subject to diversion for heroin and opioid abuse whenever appropriate among Federal offenders under supervised release. 605. Performance-based contracting for residential reentry centers (a) In general The Director of the Bureau of Prisons shall— (1) revise its policies and procedures related to contracting with providers of Residential Reentry Centers to— (A) meet the standards of performance-based contracting; and (B) include, among the standards of performance— (i) a reduction in the recidivism rate of offenders transferred to the Residential Reentry Center; and (ii) an annual evaluation of these outcomes